October 01, 2015 article Open access Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells Cancer Cell DOI: 10.1016/j.ccell.2015.09.004 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 5 stored of 847 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Chimeric Antigen Receptor T‐Cell Therapy: More Than an Anti‐Cancer Drug 2026 HLA article Medicine CAR-T cell therapy research Open access 1 citations CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors 2024 Cellular and Molecular Immunology article Immunology and Microbiology Immunotherapy and Immune Responses Open access 65 citations Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations 2023 Blood article Medicine CAR-T cell therapy research Open access cited by 1 patent 355 citations Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside? 2022 Journal for ImmunoTherapy of Cancer article Medicine CAR-T cell therapy research Open access cited by 6 patents 37 citations Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure 2022 OncoImmunology article Medicine CAR-T cell therapy research Open access cited by 2 patents 60 citations 5 results References 0